Citigroup’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Citigroup’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-598	Closed	-$155	–	5980
2025 Q1	$155	Buy	+598	New	+$251	﹤0.01%	5423

Other funds holding SYRA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citigroup's SYRA Position: Q2 2025 in Review

Citigroup sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 598 shares — an estimated $155 sold.

Citigroup first reported a position in SYRA in Q1 2025 and held it in 1 quarter. The position peaked at $155 in Q1 2025. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

Citigroup reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
Citigroup sold 598 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $155.
Citigroup first reported a position in Syra Health Corp. Class A Common Stock in Q1 2025 and held it in 1 quarter.
Citigroup's Syra Health Corp. Class A Common Stock position peaked at $155 in Q1 2025.
2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.